Pharmabiz9h
Takeda’s flagship GICC to create 750 jobs, foster technological innovation with emphasis on plasma-based therapy
Our Bureau, Bengaluru Wednesday, January 15, 2025, 16:45 Hrs [IST] ...
Pharmabiz10h
Gleneagles Hospital performs Mumbai’s first domino kidney transplant of the year for sensitized patients
Gleneagles Hospital performs Mumbai’s first domino kidney transplant of the year for sensitized patients: Our Bureau, Mumbai ...
Pharmabiz1d
Illumina launches pilot proteomics programme with UK Biobank and biopharma collaborators to analyze 50,000 samples
Illumina launches pilot proteomics programme with UK Biobank and biopharma collaborators to analyze 50,000 samples: San Diego Tuesday, January 14, 2025, 13:00 Hrs [IST] Illumina, ...
Pharmabiz1d
China NMPA approves Sanofi’s Sarclisa in combo with pomalidomide and dexamethasone to treat adult patients with R/R multiple myeloma
China NMPA approves Sanofi’s Sarclisa in combo with pomalidomide and dexamethasone to treat adult patients with R/R multiple myeloma: Paris Tuesday, January 14, 2025, 10:00 Hrs ...
Pharmabiz1d
Telix enters agreement with Curium Pharma for transfer of marketing and distribution rights for Scintimun
Telix, a commercial-stage biopharmaceutical company focused on the development and commercialisation of therapeutic and diagnostic (‘theranostic’) radiopharmaceuticals, announces that it has entered ...
Pharmabiz9h
Tata Group partners with IISc investing Rs. 500 crore to set-up medical school to pioneer healthcare education and research
Tata Group partners with IISc investing Rs. 500 crore to set-up medical school to pioneer healthcare education and research: Our Bureau, Bengaluru Wednesday, January 15, 2025, 17: ...
Pharmabiz11h
Santhera gets positive recommendation from Scottish Medicines Consortium for use of Agamree to treat Duchenne muscular dystrophy
Santhera gets positive recommendation from Scottish Medicines Consortium for use of Agamree to treat Duchenne muscular dystrophy: Pratteln, Switzerland Wednesday, January 15, 2025 ...
Pharmabiz14h
REGENXBIO & Nippon Shinyaku enter exclusive partnership to develop and commercialize RGX-121 and RGX-111 for MPS diseases
REGENXBIO & Nippon Shinyaku enter exclusive partnership to develop and commercialize RGX-121 and RGX-111 for MPS diseases: Rockville, Maryland Wednesday, January 15, 2025, 12:00 H ...
Pharmabiz17h
Daiichi Sankyo to pay $132.5 million to acquire IP rights for anti-TAMUC1 antibody in DS-3939 from Glycotope
Daiichi Sankyo to pay $132.5 million to acquire IP rights for anti-TAMUC1 antibody in DS-3939 from Glycotope: Tokyo Wednesday, January 15, 2025, 09:00 Hrs [IST] Daiichi Sankyo Com ...
Pharmabiz5d
FPME demands policy reforms to address critical issues hampering export ecosystem
The Federation of Pharmaceutical and Allied Products Merchant Exporters (FPME) has urged the authorities to address critical issues hampering India's pharmaceutical export ecosystem, highlighting the ...
Pharmabiz5d
AIPPSPA urges Kerala DCA to carry out separate inspections at discount pharmacies to ensure quality of drugs
Expressing concerns over the quality of medicines sold through discount pharmacies in Kerala, the state president of the All India Public and Private Sector Pharmacists Association (AIPPSPA), ...
Pharmabiz14h
SATB launches ‘Addressing The Twin Epidemics: Survivor Led Framework’ to integrate mental health and TB care
Survivor Led Framework’ to integrate mental health and TB care: Our Bureau, Mumbai Wednesday, January 15, 2025, 11:30 Hrs [IST] S ...